Terns Pharmaceuticals, Inc.
Clinical-stage biopharma developing small-molecule drugs for oncology & metabolic diseases.
TERN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US8808811074
- LEI:
- Country:
- United States of America
- Address:
- 1065 EAST HILLSDALE BLVD., SUITE 100, 94404 FOSTER CITY
- Website:
- https://ternspharma.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing a portfolio of small-molecule product candidates for serious unmet medical needs. The company's strategy is to innovate upon de-risked, clinically validated mechanisms of action to accelerate the development of superior therapies. Its robust, clinical-stage pipeline primarily targets oncology and metabolic diseases. Terns is actively advancing clinical programs, including its CARDINAL study for the treatment of chronic myeloid leukemia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Terns Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Terns Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Terns Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
